scispace - formally typeset
B

Balasubramanian Venkatesh

Researcher at University of New South Wales

Publications -  5
Citations -  87

Balasubramanian Venkatesh is an academic researcher from University of New South Wales. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 3, co-authored 5 publications receiving 23 citations. Previous affiliations of Balasubramanian Venkatesh include The George Institute for Global Health & Royal Brisbane and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials.

Cathrine Axfors, +230 more
- 20 Nov 2021 - 
TL;DR: In this article, the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials, were evaluated.
Journal ArticleDOI

Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: the COVID STEROID randomised, placebo-controlled trial.

Marie Warrer Munch, +76 more
- 17 Jun 2021 - 
TL;DR: The COVID STEROID trial as discussed by the authors evaluated the effects of low-dose hydrocortisone on patient-centred outcomes in adults with COVID-19 and severe hypoxia.
Journal ArticleDOI

Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis.

Anders Granholm, +49 more
- 14 Feb 2021 - 
TL;DR: In this article, a secondary, pre-planned Bayesian analysis of the primary outcome (days alive without life support at day 28) and all secondary outcomes registered up to day 90 was presented.
Journal Article

Statistical analysis plan for the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock (ADRENAL) trial.

Laurent Billot, +18 more
- 01 Jun 2017 - 
TL;DR: A standard SAP for the ADRENAL trial is developed that accords with high-quality standards of internal validity to minimise analysis bias and is made public before completion of patient recruitment and data collection.
Journal ArticleDOI

Effects of low-dose hydrocortisone and hydrocortisone plus fludrocortisone in adults with septic shock: a protocol for a systematic review and meta-analysis of individual participant data

Djillali Annane, +12 more
- 02 Dec 2020 - 
TL;DR: An individual patient data meta-analysis (IPDMA) on the effect of hydrocortisone with or without fludrocort isone compared with placebo or usual care on 90-day mortality and other outcomes in patients with septic shock is performed.